Medtronic Vascular recalls SHERPA NX Active Guiding Catheters (6F, JL4.0, 110CM) due to potential loss of primary segment material exposing steel wires. Affected units have specific model and lot numbers.
There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.
Medtronic Vascular is recalling certain SHERPA NX Active Guiding Catheters for cardiovascular use. The catheters may have a risk of losing their outer layer, exposing steel wires that could cause injury during procedures.
The catheter's primary segment material may break off, exposing the underlying stainless-steel braid wires. This could lead to complications during medical procedures if the wires become tangled or cause injury.
Cardiovascular professionals using the recalled catheters are most at risk. The recall affects specific model numbers sold with particular lot/serial numbers.
Check for the model: SHERPA NX Active Guiding Catheter, 6F, JL4.0, 110CM, 070", with reference number SA6JL40A. All units sold with specific lot or serial numbers are affected.
Review the model number and lot/serial numbers on the catheter to confirm if it matches the recalled specifications.
The recall is due to a potential loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.
The official recall notice does not specify a remedy or action steps for affected users.
Check for the model: SHERPA NX Active Guiding Catheter, 6F, JL4.0, 110CM, 070", with reference number SA6JL40A. All units sold with specific lot or serial numbers are affected.
We’ve drafted a message you can send Medtr: a short, human brand name for headings (e.g. "Trsmima") to request your refund or repair — edit it as you like.
Subject: Recall Z-2589-2019 — Medtr: a short, human brand name for headings (e.g. "Trsmima") Medtr: a short, human brand name for Hello, I own a Medtr: a short, human brand name for headings (e.g. "Trsmima") that is covered by recall Z-2589-2019 from Medtr: a short, human brand name for headings (e.g. "Trsmima"). I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
